HSD17B13 and metabolic dysfunction-associated steatotic liver disease: These limitations may be outweighed by strengths of our study using liver biopsy (still the gold standard for fibrosis assessment) in a cohort of NAFLD patients from across Central Europe with information on genetic data on three important risk factors of NAFLD (PNPLA3, HSD17B13, and TM6SF2).